These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32271355)

  • 81. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
    Epstein SP; Bottone EJ; Asbell PA
    Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2011)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Apr; 68(2):105-24. PubMed ID: 26182814
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Bacterial etiology and antimicrobial resistance trends in ocular infections: A 30-year study, Turin area, Italy.
    Grandi G; Bianco G; Boattini M; Scalabrin S; Iannaccone M; Fea A; Cavallo R; Costa C
    Eur J Ophthalmol; 2021 Mar; 31(2):405-414. PubMed ID: 31875683
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Decline in the proportion of methicillin resistance among Staphylococcus aureus isolates from non-invasive samples and in outpatient settings, and changes in the co-resistance profiles: an analysis of data collected within the Antimicrobial Resistance Surveillance Network, Germany 2010 to 2015.
    Walter J; Noll I; Feig M; Weiss B; Claus H; Werner G; Eckmanns T; Hermes J; Abu Sin M
    BMC Infect Dis; 2017 Feb; 17(1):169. PubMed ID: 28231850
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.
    Adebayo A; Parikh JG; McCormick SA; Shah MK; Huerto RS; Yu G; Milman T
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):111-9. PubMed ID: 20532549
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bacteriological profile and drug susceptibility patterns in dacryocystitis patients attending Gondar University Teaching Hospital, Northwest Ethiopia.
    Assefa Y; Moges F; Endris M; Zereay B; Amare B; Bekele D; Tesfaye S; Mulu A; Belyhun Y
    BMC Ophthalmol; 2015 Apr; 15():34. PubMed ID: 25880996
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical outcomes and antibiotic susceptibilities of Staphylococcus aureus endophthalmitis.
    Huz JI; Mukkamala K; Pagan IR; Ritterband D; Shah M; Gentile RC; Engelbert M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):651-656. PubMed ID: 27757526
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
    Pontani D; Washton H; Bouchillon S; Johnson J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):413-9. PubMed ID: 9758284
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
    Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
    Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antibiotic sensitivity of recent clinical isolates from patients with ocular infections.
    Ooishi M; Miyao M
    Ophthalmologica; 1997; 211 Suppl 1():15-24. PubMed ID: 9065933
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Surveillance for antimicrobial resistance: VIRA Study].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Azahares E; Ali Sánchez B;
    Enferm Infecc Microbiol Clin; 2002 Dec; 20(10):503-10. PubMed ID: 12433352
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United States.
    Chen X; Adelman RA
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):329-34. PubMed ID: 22506856
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2002)].
    Shimada K; Nakano K; Igari J; Oguri T; Ikemoto H; Mori T; Yokouchi H; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Okada S; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Nakata K; Nakatani T; Inagawa H; Kudo K; Kobayashi N; Tanaka T; Kobayashi H; Goto H; Kawai S; Takeda H; Sumitomo M; Matsushima T; Niki Y; Kohno S; Miyazaki Y; Yanagihara K; Hirakata Y; Matsuda J; Nasu M; Hiramatsu K; Suga M; Tosaka M
    Jpn J Antibiot; 2004 Jun; 57(3):213-45. PubMed ID: 15376784
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
    Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents.
    Fedler KA; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):427-36. PubMed ID: 16938419
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Trends in antibiotic resistance in bacterial keratitis isolates from South India.
    Lalitha P; Manoharan G; Karpagam R; Prajna NV; Srinivasan M; Mascarenhas J; Das M; Porco TC; Lietman TM; Cevallos V; Keenan JD
    Br J Ophthalmol; 2017 Feb; 101(2):108-113. PubMed ID: 27130916
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.